Gores Metropoulos Ret. on equity
What is the Ret. on equity of Gores Metropoulos?
The Ret. on equity of Gores Metropoulos, Inc. is -38.57%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Finance sector on NASDAQ compared to Gores Metropoulos
What does Gores Metropoulos do?
Gores Metropoulos, Inc. does not have signification operations. It intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or business combination. The company was founded in 2018 and is headquartered in Beverly Hills, California.
Companies with ret. on equity similar to Gores Metropoulos
- Plexus plc has Ret. on equity of -38.71%
- Nephros has Ret. on equity of -38.64%
- Two Shields Investments Plc has Ret. on equity of -38.63%
- Bioline Rx Ltd has Ret. on equity of -38.63%
- Jindal Drilling & Industries has Ret. on equity of -38.60%
- Lipocine Inc has Ret. on equity of -38.58%
- Gores Metropoulos has Ret. on equity of -38.57%
- Melco International Development has Ret. on equity of -38.56%
- Farstarcap Investment has Ret. on equity of -38.55%
- DiaMedica Therapeutics has Ret. on equity of -38.54%
- LendingTree has Ret. on equity of -38.53%
- Raiden Resources has Ret. on equity of -38.52%
- Immutep has Ret. on equity of -38.49%